CalciMedica NASDAQ: CALC www.calcimedica.com
2 known investors
CalciMedica is a clinical-stage biopharmaceutical company developing therapies that inhibit CRAC calcium channels to address acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. The company's lead compound targets conditions including acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
BiotechHealthtechMedical Devices